Please login to the form below
Ovarian canncer
This page shows the latest Ovarian canncer news and features for those working in and with pharma, biotech and healthcare.
Another NICE no for AZ’s new ovarian cancer drug
Cost watchdog wants more information for Lynparza. . NICE is once again saying no to AstraZeneca's new ovarian cancer drug - but is opening up a second consultation on its decision. ... The Institute is minded, in preliminary draft guidance, to reject
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Account Director, Medical Education
-
Salary TBC
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
-
Senior Copywriter
-
Salary TBC
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer opens AI-enabled drug discovery center in UK
- Roche reports continued growth in Q3, despite biosimilar competition
- Takeda offloads select portfolio to Acino ahead of Shire takeover
- The best in the UK healthcare system celebrated at QiC Diabetes awards 2019
- Merck wins CHMP recommendation for Ebola vaccine
- Roche scores another FDA approval for Xofluza
- CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal
- AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs
- A snapshot of Crescendo Biologics
PMHub
HAVAS Just::
HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....
Latest intelligence
- A snapshot of Crescendo Biologics
- PME talks to CEO Theodora Harold...
- eyeforpharma Marketing and Customer Innovation Europe
- By Richard Springham...
- The Golden Goose
- Why it’s so hard for the US to curb runaway drug prices...
Quick links
Infographics
